Sight Diagnostics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 130

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 13

Sight Diagnostics General Information

Description

Developer of automated microscopy device designed to improve healthcare for everyone through smart blood testing. The company offers a medical platform for diagnosing blood diseases using digital fluorescent microscopy and computer vision algorithms, enabling healthcare providers to perform multiple tests on a single, easy-to-operate platform.

Contact Information

Website
www.sightdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Derech Menachem Begin 23
  • Tel Aviv
  • Israel
+972
Primary Industry
Diagnostic Equipment
Corporate Office
  • Derech Menachem Begin 23
  • Tel Aviv
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sight Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 12-Jan-2026 Completed Generating Revenue
7. Debt - General 09-Nov-2023 Completed Generating Revenue
6. Later Stage VC (Series D) 01-Jul-2020 Completed Generating Revenue
5. Later Stage VC (Series C) 14-Feb-2019 Completed Generating Revenue
4. Early Stage VC (Series B) 01-Oct-2017 Completed Startup
3. Grant Completed Startup
2. Early Stage VC (Series A) 08-Apr-2014 $6.05M $9.2M Completed Startup
1. Angel (individual) 01-Aug-2011 $3.2M $3.2M Completed Startup
To view Sight Diagnostics’s complete valuation and funding history, request access »

Sight Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B2
Preferred B1
Preferred A 5,000,000 $1.58 $1.58 1x $1.58 25.79%
Ordinary 5,500,000 $0.85 $0.85 1x $0.85 25.44%
To view Sight Diagnostics’s complete cap table history, request access »

Sight Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of automated microscopy device designed to improve healthcare for everyone through smart blood testing. The co
Diagnostic Equipment
Tel Aviv, Israel
130 As of 2024

San Diego, CA
 

Yokneam Ilit, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sight Diagnostics Competitors (8)

One of Sight Diagnostics’s 8 competitors is Genalyte, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genalyte Venture Capital-Backed San Diego, CA
PixCell Medical Technologies Formerly VC-backed Yokneam Ilit, Israel
Truvian Venture Capital-Backed San Diego, CA
1Drop Formerly VC-backed Neuchatel, Switzerland
Abbott Corporation Abbot Park, IL
You’re viewing 5 of 8 competitors. Get the full list »

Sight Diagnostics Patents

Sight Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025120470-A1 Varying spatial coherence in a microscope system Inactive 04-Dec-2023
EP-4713685-A1 Apparatus and methods for microscopic analysis of a biological sample Pending 18-May-2023
WO-2024236537-A1 Apparatus and methods for microscopic analysis of a biological sample Inactive 18-May-2023
GB-202218615-D0 System and method for analyzing bodily samples Inactive 12-Dec-2022
US-20260212494-A1 System and method for analyzing bodily samples Pending 12-Dec-2022 G06T7/0012
To view Sight Diagnostics’s complete patent history, request access »

Sight Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sight Diagnostics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
BridgeOne Capital Venture Capital Minority
CK Hutchison Corporation Minority
Dancap Family Investment Office Family Office Minority
Koch Disruptive Technologies Venture Capital Minority
ForMED Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Sight Diagnostics FAQs

  • When was Sight Diagnostics founded?

    Sight Diagnostics was founded in 2010.

  • Where is Sight Diagnostics headquartered?

    Sight Diagnostics is headquartered in Tel Aviv, Israel.

  • What is the size of Sight Diagnostics?

    Sight Diagnostics has 130 total employees.

  • What industry is Sight Diagnostics in?

    Sight Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Sight Diagnostics a private or public company?

    Sight Diagnostics is a Private company.

  • What is Sight Diagnostics’s current revenue?

    The current revenue for Sight Diagnostics is .

  • How much funding has Sight Diagnostics raised over time?

    Sight Diagnostics has raised $124M.

  • Who are Sight Diagnostics’s investors?

    BridgeOne Capital, CK Hutchison, Dancap Family Investment Office, Koch Disruptive Technologies, and ForMED Ventures are 5 of 13 investors who have invested in Sight Diagnostics.

  • Who are Sight Diagnostics’s competitors?

    Genalyte, PixCell Medical Technologies, Truvian, 1Drop, and Abbott are some of the 8 competitors of Sight Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process